SKYE
insider transactionsSkye Bioscience, Inc. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
No open-market buys or sells this period. The trades below are grants, option exercises and gifts, which carry no market price.
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Grant·A
Director
$0
75.0K sh
Own New
-
Other·D
Chief Scientific Officer
—
12.0K sh
Own -100%
-
Grant·A
Chief Scientific Officer
—
12.0K sh
Own New
-
Other·D
Chief Scientific Officer
—
150.0K sh
Own -100%
-
Grant·A
Chief Scientific Officer
—
150.0K sh
Own New
-
Other·D
Chief Scientific Officer
—
200.0K sh
Own -100%
-
Grant·A
Chief Scientific Officer
—
200.0K sh
Own New
-
Other·D
Chief Scientific Officer
—
7.1K sh
Own -100%
-
Grant·A
Chief Scientific Officer
—
7.1K sh
Own New
-
Other·D
Chief Scientific Officer
—
75.0K sh
Own -100%
-
Grant·A
Chief Scientific Officer
—
75.0K sh
Own New
-
Other·D
Chief Scientific Officer
—
17.0K sh
Own -100%
-
Grant·A
Chief Scientific Officer
—
17.0K sh
Own New
-
Grant·A
Director
$0
75.0K sh
Own New
-
Grant·A
Director
$0
75.0K sh
Own New
-
Grant·A
Director
$0
75.0K sh
Own New
-
Other·D
Chief Operating Officer
—
75.0K sh
Own -100%
-
Grant·A
Chief Operating Officer
—
75.0K sh
Own New
-
Other·D
Chief Operating Officer
—
7.1K sh
Own -100%
-
Grant·A
Chief Operating Officer
—
7.1K sh
Own New
-
Other·D
Chief Operating Officer
—
8.0K sh
Own -100%
-
Grant·A
Chief Operating Officer
—
8.0K sh
Own New
-
Other·D
Chief Operating Officer
—
125.0K sh
Own -100%
-
Grant·A
Chief Operating Officer
—
125.0K sh
Own New
-
Other·D
Chief Operating Officer
—
22.0K sh
Own -100%
-
Grant·A
Chief Operating Officer
—
22.0K sh
Own New
-
Other·D
Chief Operating Officer
—
9.2K sh
Own -100%
-
Grant·A
Chief Operating Officer
—
9.2K sh
Own New
-
Other·D
Chief Operating Officer
—
150.0K sh
Own -100%
-
Grant·A
Chief Operating Officer
—
150.0K sh
Own New
-
Other·D
Punit Dhillon KEY
Chief Executive Officer
—
21.6K sh
Own -100%
-
Grant·A
Punit Dhillon KEY
Chief Executive Officer
—
21.6K sh
Own New
-
Other·D
Punit Dhillon KEY
Chief Executive Officer
—
9.0K sh
Own -100%
-
Grant·A
Punit Dhillon KEY
Chief Executive Officer
—
9.0K sh
Own New
-
Other·D
Punit Dhillon KEY
Chief Executive Officer
—
125.0K sh
Own -100%
-
Grant·A
Punit Dhillon KEY
Chief Executive Officer
—
125.0K sh
Own New
-
Other·D
Punit Dhillon KEY
Chief Executive Officer
—
650.0K sh
Own -100%
-
Grant·A
Punit Dhillon KEY
Chief Executive Officer
—
650.0K sh
Own New
-
Other·D
Punit Dhillon KEY
Chief Executive Officer
—
12.4K sh
Own -100%
-
Grant·A
Punit Dhillon KEY
Chief Executive Officer
—
12.4K sh
Own New
-
Other·D
Punit Dhillon KEY
Chief Executive Officer
—
36.0K sh
Own -100%
-
Grant·A
Punit Dhillon KEY
Chief Executive Officer
—
36.0K sh
Own New
-
Other·D
Punit Dhillon KEY
Chief Executive Officer
—
250.0K sh
Own -100%
-
Grant·A
Punit Dhillon KEY
Chief Executive Officer
—
250.0K sh
Own New
-
Grant·A
Director
$0
75.0K sh
Own New
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Mar 31, 2026 | Karen L. Smith | Grant A | 75.0K | $0 |
| Mar 31, 2026 | Christopher Twitty | Other D | 12.0K | — |
| Mar 31, 2026 | Christopher Twitty | Grant A | 12.0K | — |
| Mar 31, 2026 | Christopher Twitty | Other D | 150.0K | — |
| Mar 31, 2026 | Christopher Twitty | Grant A | 150.0K | — |
| Mar 31, 2026 | Christopher Twitty | Other D | 200.0K | — |
| Mar 31, 2026 | Christopher Twitty | Grant A | 200.0K | — |
| Mar 31, 2026 | Christopher Twitty | Other D | 7.1K | — |
| Mar 31, 2026 | Christopher Twitty | Grant A | 7.1K | — |
| Mar 31, 2026 | Christopher Twitty | Other D | 75.0K | — |
| Mar 31, 2026 | Christopher Twitty | Grant A | 75.0K | — |
| Mar 31, 2026 | Christopher Twitty | Other D | 17.0K | — |
| Mar 31, 2026 | Christopher Twitty | Grant A | 17.0K | — |
| Mar 31, 2026 | Andrew J. Schwab | Grant A | 75.0K | $0 |
| Mar 31, 2026 | Annalisa Jenkins | Grant A | 75.0K | $0 |
| Mar 31, 2026 | Paul A. Grayson | Grant A | 75.0K | $0 |
| Mar 31, 2026 | Tuan Tu Diep | Other D | 75.0K | — |
| Mar 31, 2026 | Tuan Tu Diep | Grant A | 75.0K | — |
| Mar 31, 2026 | Tuan Tu Diep | Other D | 7.1K | — |
| Mar 31, 2026 | Tuan Tu Diep | Grant A | 7.1K | — |
| Mar 31, 2026 | Tuan Tu Diep | Other D | 8.0K | — |
| Mar 31, 2026 | Tuan Tu Diep | Grant A | 8.0K | — |
| Mar 31, 2026 | Tuan Tu Diep | Other D | 125.0K | — |
| Mar 31, 2026 | Tuan Tu Diep | Grant A | 125.0K | — |
| Mar 31, 2026 | Tuan Tu Diep | Other D | 22.0K | — |
| Mar 31, 2026 | Tuan Tu Diep | Grant A | 22.0K | — |
| Mar 31, 2026 | Tuan Tu Diep | Other D | 9.2K | — |
| Mar 31, 2026 | Tuan Tu Diep | Grant A | 9.2K | — |
| Mar 31, 2026 | Tuan Tu Diep | Other D | 150.0K | — |
| Mar 31, 2026 | Tuan Tu Diep | Grant A | 150.0K | — |
| Mar 31, 2026 | Punit Dhillon KEY | Other D | 21.6K | — |
| Mar 31, 2026 | Punit Dhillon KEY | Grant A | 21.6K | — |
| Mar 31, 2026 | Punit Dhillon KEY | Other D | 9.0K | — |
| Mar 31, 2026 | Punit Dhillon KEY | Grant A | 9.0K | — |
| Mar 31, 2026 | Punit Dhillon KEY | Other D | 125.0K | — |
| Mar 31, 2026 | Punit Dhillon KEY | Grant A | 125.0K | — |
| Mar 31, 2026 | Punit Dhillon KEY | Other D | 650.0K | — |
| Mar 31, 2026 | Punit Dhillon KEY | Grant A | 650.0K | — |
| Mar 31, 2026 | Punit Dhillon KEY | Other D | 12.4K | — |
| Mar 31, 2026 | Punit Dhillon KEY | Grant A | 12.4K | — |
| Mar 31, 2026 | Punit Dhillon KEY | Other D | 36.0K | — |
| Mar 31, 2026 | Punit Dhillon KEY | Grant A | 36.0K | — |
| Mar 31, 2026 | Punit Dhillon KEY | Other D | 250.0K | — |
| Mar 31, 2026 | Punit Dhillon KEY | Grant A | 250.0K | — |
| Mar 31, 2026 | Deborah H. Charych | Grant A | 75.0K | $0 |
About SKYE insider trading
This page tracks insider transactions for Skye Bioscience, Inc. (SKYE) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.